Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity. A Report by the American Academy of Ophthalmology

Deborah K. VanderVeen, Michele Melia, Michael B. Yang, Amy K. Hutchinson, Lorri Wilson, Scott R. Lambert

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity. A Report by the American Academy of Ophthalmology'. Together they form a unique fingerprint.

Medicine & Life Sciences